Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $63K 176 sh |
| Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector |  PSMTPRICESMART INCOpen-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLOClough Global Opportunities FundOpen-market purchase | BUY | $1,274 213 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLVClough Global Dividend & Income FundOpen-market purchase | BUY | $774 124 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 38 | Allison EricChief Product Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 37 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $34K 200.0K sh | Jan 14, 2026 traded Jan 8, 2026 |
| 37 | Baker Bruce DDirector |  CMTVCOMMUNITY BANCORP /VTOpen-market purchase | BUY | $5,040 180 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $9,361 25 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $35K 98 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $32K 87 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $28K 76 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $27K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $467K 5,182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $13K 36 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Bevirt JoeBenDirector, CEO and Chief Architect, 10% Owner | JOBYJoby Aviation, Inc. Open-market sale | SELL | $24K 1,630 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 36 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $2.49M 22.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.62M 14.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $6,676 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K